Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia

Homeostasis: apoptosis and cell cycle in normal and pathological prostate

(2018) Norelia Torrealba et al.   Aging Male

PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer

(2018) Norelia Torrealba et al.   Aging Male

Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer

(2018) Nikos Koundouros et al.   Frontiers in Oncology

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients

(2017) Shujiao He et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

AR Signaling and the PI3K Pathway in Prostate Cancer

(2017) Megan Crumbaker et al.   Cancers

Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer

(2016) Trinath P. Das et al.   CANCER LETTERS

The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms

(2016) Kathryn Brigham Egan   UROLOGIC CLINICS OF NORTH AMERICA

Insulin, insulin receptors, and cancer

(2016) R. Vigneri et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

(2015) Gonzalo Rodríguez-Berriguete et al.   BMC CANCER

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways

(2014) L Chang et al.   Cell Death & Disease

PIK3R1 underexpression is an independent prognostic marker in breast cancer

(2013) Magdalena Cizkova et al.   BMC CANCER

Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

(2013) J. Dulinska-Litewka et al.   CURRENT MEDICINAL CHEMISTRY

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

(2013) Rhonda L Bitting et al.   ENDOCRINE-RELATED CANCER

Hyperglycemia, Hyperinsulinemia, Insulin Resistance, and the Risk of BPH/LUTS Severity and Progression Over Time in Community Dwelling Black Men: The Flint Men's Health Study

(2013) Lauren P. Wallner et al.   UROLOGY

High-Fat Diet Obesity Associated With Insulin Resistance Increases Cell Proliferation, Estrogen Receptor, and PI3K Proteins in Rat Ventral Prostate

(2012) D. L. Ribeiro et al.   JOURNAL OF ANDROLOGY

Akt signalling in health and disease

(2011) Ingeborg Hers et al.   CELLULAR SIGNALLING

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

The Phosphoinositide 3-Kinase Regulatory Subunit p85  Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling

(2010) C. M. Taniguchi et al.   CANCER RESEARCH

Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics

(2009) Bo Dai et al.   BJU INTERNATIONAL

Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers

(2008) Q Zhu et al.   ONCOGENE

PI3K pathway alterations in cancer: variations on a theme

(2008) T L Yuan et al.   ONCOGENE